Literature DB >> 31608949

DeepScreening: a deep learning-based screening web server for accelerating drug discovery.

Zhihong Liu1, Jiewen Du2, Jiansong Fang3, Yulong Yin1, Guohuan Xu1, Liwei Xie1,4.   

Abstract

Deep learning contributes significantly to researches in biological sciences and drug discovery. Previous studies suggested that deep learning techniques have shown superior performance to other machine learning algorithms in virtual screening, which is a critical step to accelerate the drug discovery. However, the application of deep learning techniques in drug discovery and chemical biology are hindered due to the data availability, data further processing and lacking of the user-friendly deep learning tools and interface. Therefore, we developed a user-friendly web server with integration of the state of art deep learning algorithm, which utilizes either the public or user-provided dataset to help biologists or chemists perform virtual screening either the chemical probes or drugs for a specific target of interest. With DeepScreening, user could conveniently construct a deep learning model and generate the target-focused de novo libraries. The constructed classification and regression models could be subsequently used for virtual screening against the generated de novo libraries, or diverse chemical libraries in stock. From deep models training to virtual screening, and target focused de novo library generation, all those tasks could be finished with DeepScreening. We believe this deep learning-based web server will benefit to both biologists and chemists for probes or drugs discovery.
© The Author(s) 2019. Published by Oxford University Press.

Entities:  

Mesh:

Year:  2019        PMID: 31608949      PMCID: PMC6790966          DOI: 10.1093/database/baz104

Source DB:  PubMed          Journal:  Database (Oxford)        ISSN: 1758-0463            Impact factor:   3.451


  35 in total

1.  Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.

Authors:  Timo Heinrich; Jeyaprakashnarayanan Seenisamy; Beatrix Blume; Jörg Bomke; Michel Calderini; Uwe Eckert; Manja Friese-Hamim; Rainer Kohl; Martin Lehmann; Birgitta Leuthner; Djordje Musil; Felix Rohdich; Frank T Zenke
Journal:  J Med Chem       Date:  2019-05-02       Impact factor: 7.446

2.  Deep neural nets as a method for quantitative structure-activity relationships.

Authors:  Junshui Ma; Robert P Sheridan; Andy Liaw; George E Dahl; Vladimir Svetnik
Journal:  J Chem Inf Model       Date:  2015-02-17       Impact factor: 4.956

Review 3.  Artificial intelligence in drug development: present status and future prospects.

Authors:  Kit-Kay Mak; Mallikarjuna Rao Pichika
Journal:  Drug Discov Today       Date:  2018-11-22       Impact factor: 7.851

4.  LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.

Authors:  Minghao Zheng; Zhihong Liu; Xin Yan; Qianzhi Ding; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

5.  Reinforced Adversarial Neural Computer for de Novo Molecular Design.

Authors:  Evgeny Putin; Arip Asadulaev; Yan Ivanenkov; Vladimir Aladinskiy; Benjamin Sanchez-Lengeling; Alán Aspuru-Guzik; Alex Zhavoronkov
Journal:  J Chem Inf Model       Date:  2018-06-12       Impact factor: 4.956

6.  Dermatologist-level classification of skin cancer with deep neural networks.

Authors:  Andre Esteva; Brett Kuprel; Roberto A Novoa; Justin Ko; Susan M Swetter; Helen M Blau; Sebastian Thrun
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

7.  Structural activity relationship of flavonoids with estrogen-related receptor gamma.

Authors:  Zhiyan Huang; Fang Fang; Junjian Wang; Chi-Wai Wong
Journal:  FEBS Lett       Date:  2010-01-04       Impact factor: 4.124

8.  Molecular de-novo design through deep reinforcement learning.

Authors:  Marcus Olivecrona; Thomas Blaschke; Ola Engkvist; Hongming Chen
Journal:  J Cheminform       Date:  2017-09-04       Impact factor: 5.514

9.  Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.

Authors:  Andreas Mayr; Günter Klambauer; Thomas Unterthiner; Marvin Steijaert; Jörg K Wegner; Hugo Ceulemans; Djork-Arné Clevert; Sepp Hochreiter
Journal:  Chem Sci       Date:  2018-06-06       Impact factor: 9.825

10.  Network-based approach to prediction and population-based validation of in silico drug repurposing.

Authors:  Feixiong Cheng; Rishi J Desai; Diane E Handy; Ruisheng Wang; Sebastian Schneeweiss; Albert-László Barabási; Joseph Loscalzo
Journal:  Nat Commun       Date:  2018-07-12       Impact factor: 14.919

View more
  9 in total

1.  CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling.

Authors:  Limeng Pu; Manali Singha; Jagannathan Ramanujam; Michal Brylinski
Journal:  Oncotarget       Date:  2022-05-19

Review 2.  The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions.

Authors:  Rameez Hassan Pirzada; Nasir Javaid; Sangdun Choi
Journal:  Genes (Basel)       Date:  2020-01-27       Impact factor: 4.096

Review 3.  Proving the Mode of Action of Phytotoxic Phytochemicals.

Authors:  Stephen O Duke; Zhiqiang Pan; Joanna Bajsa-Hirschel
Journal:  Plants (Basel)       Date:  2020-12-11

4.  Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis.

Authors:  Mahesha Nand; Priyanka Maiti; Tushar Joshi; Subhash Chandra; Veena Pande; Jagdish Chandra Kuniyal; Muthannan Andavar Ramakrishnan
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

Review 5.  Deep learning tools for advancing drug discovery and development.

Authors:  Sagorika Nag; Anurag T K Baidya; Abhimanyu Mandal; Alen T Mathew; Bhanuranjan Das; Bharti Devi; Rajnish Kumar
Journal:  3 Biotech       Date:  2022-04-09       Impact factor: 2.893

6.  Identification of Zinc-Binding Inhibitors of Matrix Metalloproteinase-9 to Prevent Cancer Through Deep Learning and Molecular Dynamics Simulation Approach.

Authors:  Shalini Mathpal; Priyanka Sharma; Tushar Joshi; Veena Pande; Shafi Mahmud; Mi-Kyung Jeong; Ahmad J Obaidullah; Subhash Chandra; Bonglee Kim
Journal:  Front Mol Biosci       Date:  2022-03-31

7.  DenovoProfiling: A webserver for de novo generated molecule library profiling.

Authors:  Zhihong Liu; Jiewen Du; Ziying Lin; Ze Li; Bingdong Liu; Zongbin Cui; Jiansong Fang; Liwei Xie
Journal:  Comput Struct Biotechnol J       Date:  2022-08-02       Impact factor: 6.155

8.  DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development.

Authors:  Qiang Li; Shiyong Ma; Xuelu Zhang; Zhaoyu Zhai; Lu Zhou; Haodong Tao; Yachen Wang; Jianbo Pan
Journal:  Database (Oxford)       Date:  2022-02-09       Impact factor: 4.462

9.  Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.

Authors:  Haiping Zhang; Konda Mani Saravanan; Yang Yang; Md Tofazzal Hossain; Junxin Li; Xiaohu Ren; Yi Pan; Yanjie Wei
Journal:  Interdiscip Sci       Date:  2020-06-01       Impact factor: 2.233

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.